Immatics
tolerability data cohort gen | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
29 of 75
Similar slides by Immatics
See diffirences between slides (animation)
Investor Presentation
November 2023
gen at tolerability data | Immatics
Investor Presentation
November 2023
gen across all dose levels tolerability data | Immatics
Results
October 2022
tolerability profile all grade adverse events voe | Immatics
Related slides by other companies
Compass Therapeutics
Investor Presentation
February 2023
phase safety data hei as observed in patient | Compass Therapeutics
Nuvalent
Investor Presentation
April 2024
preliminary safety profile favorable and consistent with the highly selective sparing design of phase treatment related adverse events in patient all treated patients no no treatment related no aes leading to dose reduction or discontinuation no treatment related fatigue alt increased ast increased myalgia grade grade any grade grade ses alt aint as aspartate source a doe serous ses i | Nuvalent
Compass Therapeutics
Investor Presentation
May 2023
phase safety data | Compass Therapeutics
Nuvalent
Investor Presentation
January 2024
preliminary safety profile favorable and consistent with alk selective sparing design of phase has not been identified transient asymptomatic grade increase treatment related adverse events in patients all treated patients grade grade grade any grade infrequent requiring dose any modification discontinued due to dose reduced due to overall avoiding related alt increased ast increased nausea constipation fatigue peripheral edema data cut off alt alanine ast aspartate creatinine dose limiting toxicity treatment related adverse event resulting in treatment discontinuation were grade alt grade ast elevations intolerable grade constipation occurred at following dose increase from resulting in dose reduction were grade alt ast elevation grade alt ast elevation grade nausea cognitive disturbance grade elevation grade treatment continues at the reduced dose for these patients source lin on | Nuvalent
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights